U.S. Industrials Stock News

Why Truist Financial is on investors’ radar Truist Financial (TFC) is back in focus after recent trading left the shares with a mixed return profile, including a small 1 day pullback but gains over the month and past 3 months. See our latest analysis for Truist Financial. While the 1 day share price return of a 0.33% decline to US$51.90 and the 7 day share price return of a 7.01% decline hint at some cooling after recent strength, the 30 day and 90 day share price returns of 3.82% and 18.17%...

In recent days, TJX Companies has drawn renewed attention as multiple Wall Street firms reiterated positive ratings, short interest eased, and investors looked ahead to the company’s upcoming fourth-quarter and full-year Fiscal 2026 earnings release and conference call held on February 25, 2026. Together with favorable earnings estimate revisions and a strong ranking from Zacks, these developments point to improving sentiment around TJX’s off-price retail model as it prepares to update the...

The board of Koppers Holdings Inc. ( NYSE:KOP ) has announced that the dividend on 23rd of March will be increased to...

Shareholders might have noticed that Mastercard Incorporated ( NYSE:MA ) filed its annual result this time last week...

Gold.com, Inc. ( NYSE:GOLD ) stock is about to trade ex-dividend in four days. The ex-dividend date is one business day...

As you might know, Sensus Healthcare, Inc. ( NASDAQ:SRTS ) last week released its latest annual, and things did not...

To the annoyance of some shareholders, Sabre Corporation ( NASDAQ:SABR ) shares are down a considerable 26% in the last...

The Creative Global Technology Holdings Limited ( NASDAQ:CGTL ) share price has softened a substantial 39% over the...

Alliance Entertainment Holding Corporation ( NASDAQ:AENT ) shares have had a horrible month, losing 29% after a...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

1-800-FLOWERS.COM, Inc. ( NASDAQ:FLWS ) shares have retraced a considerable 25% in the last month, reversing a fair...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Elutia Inc. ( NASDAQ:ELUT ) shares have continued their recent momentum with a 28% gain in the last month alone. But...

To the annoyance of some shareholders, Cosmos Health Inc. ( NASDAQ:COSM ) shares are down a considerable 27% in the...

Investors may wish to note that the CEO, President & Director of Sagimet Biosciences Inc. , David Happel, recently...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

SLB (SLB) has secured multiple offshore drilling and well services contracts from Mubadala Energy for the Tangkulo deepwater natural gas project in Indonesia, highlighting the company’s offshore technologies and integrated model for investors. See our latest analysis for SLB. These new offshore awards arrive after a string of contract wins and technology partnerships. The share price reflects that momentum, with a 30 day share price return of 7.83% and a 90 day share price return of 40.75%,...

Phillips 66 recently reported fourth-quarter 2025 revenue of US$36,333 million and net income of US$2,906 million, and the board has approved a quarterly dividend of US$1.27 per share, payable on March 4, 2026, to shareholders of record on February 23, 2026. The combination of markedly higher quarterly earnings and a 5.8% dividend increase underscores how the company is using improved performance and portfolio changes to support shareholder payouts. We'll now examine how Phillips 66's...

Why Ridgepost Capital Is On Investors’ Radar Ridgepost Capital (RPC) recently rebranded from P10, Inc. This shift is putting fresh attention on how this multi asset class private market solutions provider is positioned across private equity, venture capital, impact investing, and private credit. See our latest analysis for Ridgepost Capital. At a latest share price of $8.70, Ridgepost Capital has seen a 2.35% 1 day share price return. Its 30 day share price return of 18.77% and 1 year total...

In February 2026, NovoCure announced that the U.S. FDA approved Optune Pax for adult patients with locally advanced pancreatic cancer, to be used alongside gemcitabine and nab-paclitaxel after the Phase 3 PANOVA-3 trial showed a statistically significant overall survival benefit without adding meaningful systemic side effects. This approval marks the first new treatment option for locally advanced pancreatic cancer in decades and further validates NovoCure’s Tumor Treating Fields technology...

In February 2026, Arista Networks reported fourth-quarter 2025 results showing revenue of about US$2.49 billion and net income of roughly US$955.8 million, and issued first-quarter 2026 revenue guidance of approximately US$2.60 billion. The company’s performance highlighted strong demand for its AI and cloud networking portfolio, with management also signaling resilient margins despite supply-chain and memory cost pressures. Next, we’ll examine how Arista’s stronger-than-expected AI and...

In late January, BioDlink announced the successful go-live of Veeva QMS across four core GMP quality processes, reinforcing Veeva Systems’ role in life sciences quality digitalization. This client deployment highlights how Veeva’s cloud-based quality platform is becoming embedded in end-to-end operations for innovative therapy development and manufacturing partners. Next, we’ll examine how BioDlink’s Veeva QMS go-live and optimism around upcoming results shape Veeva Systems’ broader...

In February 2026, Toast reported fourth-quarter 2025 revenue of US$1,633 million and net income of US$101 million, with full-year revenue reaching US$6.15 billion and net income of US$342 million, both higher than the prior year. Management highlighted rapid adoption of its AI-powered ToastIQ assistant, already used by over half of customer locations, as a key driver of recurring gross profit growth and expanding margins. We’ll now examine how Toast’s stronger profitability and...

On December 31, 2025, FMR LLC reduced its stake in Day One Biopharmaceuticals by 4,380,660 shares, cutting its position by 43.38% but still holding 5,717,008 shares, or 5.60% of the company. This large shift by a major institutional holder may prompt investors to reassess how Day One Biopharmaceuticals fits within broader biotechnology portfolios. Next, we’ll examine how FMR LLC’s sizeable reduction in ownership could influence Day One Biopharmaceuticals’ investment narrative and risk...